Development and anticancer properties of Up284, a spirocyclic candidate ADRM1/RPN13 inhibitor. Anchoori RK, Anchoori V, Lam B, Tseng SH, et al. PLoS One 2023;18:e0285221.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Anchoori RK, Anchoori V, Lam B, Tseng SH, et al. Development and anticancer properties of Up284, a spirocyclic candidate ADRM1/RPN13 inhibitor. PLoS One 2023;18:e0285221.
PMID: 37315065